Publications by authors named "Stephane Mouret"

Claim this Profile
E
Efficacy of olaparib combined with dabrafenib and trametinib for a patient with BRAF mutated and ATM deleted metastatic melanoma.
Theo Marguet, Stéphane Mouret, Aude Belbézier, Camila Castillo-Ferrer, Lucie Sancey

J Eur Acad Dermatol Venereol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soluble VE-cadherin as a biomarker of response to immunotherapy by anti-PD1 in metastatic melanoma.
Clémentine Broche, Khémary Um, Isabelle Vilgrain, Stéphane Mouret, Marie-Thérèse Leccia

Br J Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Home anti-PD1 immunotherapy for melanoma: results of a patient and nursing satisfaction survey.
Thu Thao Truong, Marie Lapassat, Aude Belbezier, Marie-Thérèse Leccia, Stéphane Mouret

Eur J Dermatol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MCT1 lactate transporter blockade re-invigorates anti-tumor immunity through metabolic rewiring of dendritic cells in melanoma.
Camille Niveau, Mélanie Cettour-Cave, Stéphane Mouret, Eleonora Sosa Cuevas, Mylene Pezet

Nat Commun· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of adjuvant lymph node field radiotherapy and immunotherapy for stage III melanoma.
Léa Marxgut, Andréa Desagneaux, Alexandre Bellier, Stéphane Mouret, Julie Charles

Cancer Radiother· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating immune landscape in melanoma patients undergoing anti-PD1 therapy reveals key immune features according to clinical response to treatment.
Eleonora Sosa Cuevas, Stéphane Mouret, Guillaume Vayssière, Siham Kerboua, Pauline Girard

Front Immunol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecularly matched targeted therapy: a promising approach for refractory metastatic melanoma.
Emily Connell, Émilie Gerard, Bénédicte Oules, Florence Brunet-Possenti, Anouck Lamoureux, Stéphane Mouret

Oncologist· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum IGF1 Is a Prognostic Marker for Resistance to Targeted Therapies and a Predictive Marker for Anti-IGF1 Receptor Therapy in Melanoma.
Camila Castillo-Ferrer, Théo Marguet, Laetitia Vanwonterghem, Sule Erbek, Florent Chuffart, Stéphane Mouret

J Invest Dermatol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melanoma tumour-derived glycans hijack dendritic cell subsets through C-type lectin receptor binding.
Camille Niveau, Eleonora Sosa Cuevas, Benoît Roubinet, Mylène Pezet, Michel Thépaut, Stéphane Mouret

Immunology· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term response of vulvar mucosal melanoma treated with neoadjuvant nivolumab.
Margaux Dubus, Julie Charles, Marie-Thérèse Leccia, Stéphane Mouret, Sabiha Trabelsi

JAAD Case Rep· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The melanoma tumor glyco-code impacts human dendritic cells' functionality and dictates clinical outcomes.
Eleonora Sosa Cuevas, Benoît Roubinet, Stephane Mouret, Michel Thépaut, Florence de Fraipont

Front Immunol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Skin cancers under Janus kinase inhibitors: A World Health Organization drug safety database analysis.
Cédric Jalles, Marion Lepelley, Stéphane Mouret, Julie Charles, Marie-Thérèse Leccia

Therapie· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unique CLR expression patterns on circulating and tumor-infiltrating DC subsets correlated with clinical outcome in melanoma patients.
Eleonora Sosa Cuevas, Jenny Valladeau-Guilemond, Stephane Mouret, Benoît Roubinet, Florence de Fraipont

Front Immunol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diversification of circulating and tumor-infiltrating plasmacytoid DCs towards the P3 (CD80 PDL1)-pDC subset negatively correlated with clinical outcomes in melanoma patients.
Eleonora Sosa Cuevas, Nathalie Bendriss-Vermare, Stephane Mouret, Florence De Fraipont, Julie Charles

Clin Transl Immunology· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dysfunctional BTN3A together with deregulated immune checkpoints and type I/II IFN dictate defective interplay between pDCs and γδ T cells in melanoma patients, which impacts clinical outcomes.
Pauline Girard, Eleonora Sosa Cuevas, Benedicte Ponsard, Stephane Mouret, Hugo Gil

Clin Transl Immunology· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BDCA1 cDC2s, BDCA2 pDCs and BDCA3 cDC1s reveal distinct pathophysiologic features and impact on clinical outcomes in melanoma patients.
Eleonora Sosa Cuevas, Laurissa Ouaguia, Stephane Mouret, Julie Charles, Florence De Fraipont

Clin Transl Immunology· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-cell receptor diversity as a prognostic biomarker in melanoma patients.
Julie Charles, Stephane Mouret, Isabelle Challende, Marie-Therese Leccia, Florence De Fraipont

Pigment Cell Melanoma Res· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The features of circulating and tumor-infiltrating γδ T cells in melanoma patients display critical perturbations with prognostic impact on clinical outcome.
Pauline Girard, Julie Charles, Camille Cluzel, Emmanuelle Degeorges, Olivier Manches, Stephane Mouret

Oncoimmunology· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma Circulating Tumor DNA Levels for the Monitoring of Melanoma Patients: Landscape of Available Technologies and Clinical Applications.
Benoit Busser, Julien Lupo, Lucie Sancey, Stéphane Mouret, Patrice Faure

Biomed Res Int· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The avidity of tumor-specific T cells amplified by a plasmacytoid dendritic cell-based assay can predict the clinical evolution of melanoma patients.
Julie Charles, Laurence Chaperot, Bruno Revol, Marine Baudin, Stephane Mouret

Pigment Cell Melanoma Res· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of topical application of sulfur mustard on mice skin and distant organs DNA repair enzyme signature.
Sylvie Sauvaigo, Fanny Sarrazy, Mohamed Batal, Sylvain Caillat, Benoit Pitiot, Stéphane Mouret

Toxicol Lett· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A guanine-ethylthioethyl-glutathione adduct as a major DNA lesion in the skin and in organs of mice exposed to sulfur mustard.
Mohamed Batal, Silvestre Rebelo-Moreira, Nadège Hamon, Pierre-Alain Bayle, Stéphane Mouret

Toxicol Lett· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time course of skin features and inflammatory biomarkers after liquid sulfur mustard exposure in SKH-1 hairless mice.
Stéphane Mouret, Julien Wartelle, Mohamed Batal, Sandy Emorine, Marine Bertoni

Toxicol Lett· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time course of lewisite-induced skin lesions and inflammatory response in the SKH-1 hairless mouse model.
Nina Nguon, Cécile Cléry-Barraud, Virginie Vallet, Nacéra Elbakdouri, Julien Wartelle, Stéphane Mouret

Wound Repair Regen· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA damage in internal organs after cutaneous exposure to sulphur mustard.
Mohamed Batal, Isabelle Boudry, Stéphane Mouret, Cécile Cléry-Barraud, Julien Wartelle

Toxicol Appl Pharmacol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis